| UTRESVYQ GLAXO GROUP LIMITED 2193095 23 May 2022 | on 12 Jan 2024 | Pharmaceutical preparations for use as anti-infectives; pharmaceutical... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders, namely autoimmune diseases and disorders; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders, namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders, namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment, namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; pharmaceutical preparations for the treatment of blood-related diseases and disorders, namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders, namely dermatitis, skin and skin structure infections, namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders, namely hypogonadism, testosterone/androgen disorders and estrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders, namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders; pharmaceutical preparations for the treatment of sexual dysfunction, namely erectile dysfunction, male and female sexual dysfunction disorders, namely arousal disorder, pain disorder, desire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases and disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders, namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical hormonal preparations, namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, leiomyoma, endourology/stone, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders, namely polycystic ovary syndrome; pharmaceutical preparations for the treatment of hepatological related diseases, namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of damaged skin and tissue, namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medications; vaccines, namely prophylactic and therapeutic vaccines for humans; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely Parkinsons Disease, Alzheimers Disease, Huntingtons Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders, namely schizophrenia and psychoses; pharmaceutical preparations for the treatment of muscular dystrophy. | |
| KEPZAVYQ GLAXO GROUP LIMITED 2193076 20 May 2022 | on 12 Jan 2024 | Pharmaceutical preparations for use as anti-infectives; pharmaceutical... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders, namely autoimmune diseases and disorders; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders, namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders, namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment, namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; pharmaceutical preparations for the treatment of blood-related diseases and disorders, namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders, namely dermatitis, skin and skin structure infections, namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders, namely hypogonadism, testosterone/androgen disorders and estrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders, namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders; pharmaceutical preparations for the treatment of sexual dysfunction, namely erectile dysfunction, male and female sexual dysfunction disorders, namely arousal disorder, pain disorder, desire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases and disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders, namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical hormonal preparations, namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, leiomyoma, endourology/stone, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders, namely polycystic ovary syndrome; pharmaceutical preparations for the treatment of hepatological related diseases, namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of damaged skin and tissue, namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medications; vaccines, namely prophylactic and therapeutic vaccines for humans; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely Parkinsons Disease, Alzheimers Disease, Huntingtons Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders, namely schizophrenia and psychoses; pharmaceutical preparations for the treatment of muscular dystrophy; pharmaceutical preparations and substances for the treatment and/or alleviation of nephrological related diseases and disorders. | |
| TRUSVYQ GLAXO GROUP LIMITED 2193091 20 May 2022 | on 12 Jan 2024 | Pharmaceutical preparations for use as anti-infectives; pharmaceutical... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders, namely autoimmune diseases and disorders; pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus, respiratory syncytial virus, hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders, namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders, namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment, namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; pharmaceutical preparations for the treatment of blood-related diseases and disorders, namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the treatment of dermatological diseases and disorders, namely dermatitis, skin and skin structure infections, namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders, namely hypogonadism, testosterone/androgen disorders and estrogen disorders; pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders, namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders; pharmaceutical preparations for the treatment of sexual dysfunction, namely erectile dysfunction, male and female sexual dysfunction disorders, namely arousal disorder, pain disorder, desire disorder and orgasm disorder; pharmaceutical preparations for the treatment of genitourinary diseases, namely urological diseases and disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders, namely amenorrhoea, dysmenorrheal and infertility; pharmaceutical hormonal preparations, namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, leiomyoma, endourology/stone, pre-eclampsia and pre-term labour; pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders, namely polycystic ovary syndrome; pharmaceutical preparations for the treatment of hepatological related diseases, namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of damaged skin and tissue, namely bee stings, sunburn, rashes, sores, corns, calluses and acne; pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; pharmaceutical preparations for the treatment of malaria; pharmaceutical preparations for the treatment of tuberculosis; allergy medications; vaccines, namely prophylactic and therapeutic vaccines for humans; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely Parkinsons Disease, Alzheimers Disease, Huntingtons Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders, namely schizophrenia and psychoses; pharmaceutical preparations for the treatment of muscular dystrophy. | |
| myQ The Chamberlain Group LLC 2120182 13 Jul 2021 | on 19 Dec 2024 | Electric door and gate opening and closing systems; Garage door and ga... Class 007 Class 007 Machinery Products Electric door and gate opening and closing systems; Garage door and gate openers; Controller systems for loading docks, warehouse shipping and receiving areas, manufacturing distribution areas and truck transfer areas and components thereof, namely, equipment for installation at a loading dock, consisting of dock levelers, powered vehicle restraints, electric overhead door openers, powered ramps, truck levelers, powered safety barriers, in the nature of powered vehicle stops and restraints, toe guards, and powered loading dock seals Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Electric door and gate opening and closing systems; Remote controls for doors, gates, lights, light switches, electrical plugs and sockets, cameras and door locks; Electronic transmitters for controlling door and gate operators, lights and lighting systems, light switches, electrical plugs and sockets, cameras and door locks, and providing status of same; Lighting controls; Lights and lighting systems; Light switches; Electrical plugs and sockets; Power controllers; Electronic actuators; Electronic readers and controllers for controlling access to a premises or secured area; Radio receiver units; Radio transmitter units; Keypads for use with door and gate operators; Access control systems for providing and restricting access to electronically monitored and/or secured enclosures, premises or areas; Access control and alarm monitoring systems; Home, office and industrial automation systems comprising wireless and wired controllers, controlled devices, and software for lighting, HVAC, security, safety and other home, office and industrial monitoring and control applications; Electronic transmitter- controller and automated pet door combination sold as a unit; Electronic transmitters that activate automated pet doors; Magnetic devices that activate self-unlocking pet doors; Automated pet doors with integrated digital cameras; Communications hubs; Electronic hubs for connecting internet of things (IoT) enabled devices; Controllers for internet of things (IoT) enabled devices; Home, office and industrial automation systems comprised of computer hardware, wireless and wired controllers, and downloadable software for automating appliances, lighting, security, electrical power, doors, gates, locks and cameras; Computer hardware and software systems for remotely controlling lights and lighting devices, light switches, electrical plugs and outlets, access devices, security devices, locks, and cameras within a building or building perimeter; Electronic security devices, namely, electronic controls for granting access and egress through doors or gates; cameras; Electric and electronic video surveillance installations; Computer application software for mobile communication and computing devices for communicating with garage door and gate operators, lights and lighting systems, light switches, electrical plugs and sockets, locks and cameras and door locks, and providing status of same; Downloadable mobile applications and computer application software for mobile devices, namely, mobile phones, tablet computers, personal computers, and vehicle infotainment systems for accessing and controlling internet of things (IoT) enabled devices, namely, door and gate operators, lights and lighting systems, light switches, electrical plugs and outlets, locks and cameras, and electronic locks; and Computer software for opening doors, controlling machinery, operating lights, collecting loading dock data, conducting equipment diagnostics and communicating with remote data collection devices; Software to run wireless digital video camera monitoring systems but not including home automation systems and apparatuses relating to window coverings, including window screens, draperies, blinds and other window-related coverings | |
| MIRYQ COHERUS BIOSCIENCES INC. 2071739 13 Nov 2020 | | Pharmaceutical preparations for the treatment of autoimmune diseases. Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of autoimmune diseases. | |
| UBYQ MADAME AFIDA BENSAOUD; MONSIEUR XAVIER RICHARD 2049414 6 Jul 2020 | on 1 Nov 2022 | Appareils et instruments scientifiques, nautiques, géodésiques, photog... Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Appareils et instruments scientifiques, nautiques, géodésiques, photographiques, cinématographiques, optiques, de pesage, de mesurage, de signalisation, de contrôle (inspection), de secours (sauvetage) et d'enseignement, appareils pour l'enregistrement, la transmission, la reproduction du son ou des images, supports d'enregistrement magnétique, disques acoustiques; sacs et étuis pour appareils photographiques ou caméras vidéo; disques compacts, DVD et autres supports d'enregistrement numériques; machines à calculer, équipement pour le traitement de l'information, ordinateurs et équipement pour les ordinateurs; tapis de souris; logiciels; clé USB, agendas électroniques, publications électroniques téléchargeables on-line ou depuis l'Internet; housses pour ordinateurs portables; sacoches conçues pour ordinateurs portables; appareils photographiques; téléphones, téléphones portables, smart phones, tablettes, assistants personnels électroniques et lecteurs MP3; accessoires pour téléphones, téléphones portables, smartphones, tablettes, PDA, et lecteurs MP3, à savoir nécessaires mains libres pour téléphones, batteries, housses, coques, façades, chargeurs, dragonnes ou lanières tour de cou, écouteurs; sacs et étuis pour téléphones portables et équipements téléphoniques; dispositifs d'affichage à diodes électroluminescentes; clés USB vierges; cartes mémoire flash vierges; routeurs de réseau; serrures numériques; panneaux d'affichage numérique; semi-conducteurs; chargeurs de batterie pour téléphones portables, tablettes et ordinateurs portables; vidéoprojecteurs; décodeurs, montres intelligentes; disques SSD, coques de protection pour smartphones; haut-parleurs; composants électroniques audio à savoir systèmes de son tétraphonique; ordinateurs portables sous forme de montres intelligentes et de lunettes intelligentes; capteurs électriques; moniteur d'activité physique portable; piles électriques rechargeables; appareils photographiques; ordinateurs; moniteurs d'ordinateur (matériel informatique), tablettes électroniques; appareils de télévision; écouteurs; ordinateurs portables dispositifs périphériques pour ordinateurs; terminaux à écran tactile interactif; tableaux d'affichage électroniques; circuits à induction mutuelle; écrans tactiles; cartes de circuits imprimés souples; écrans; écrans souples; à l'exclusion des produits liés au divertissement en général et en particulier le domaine du jeu vidéo, des programmes informatiques de divertissement et des applications interactives de divertissement. Class 018 Class 018 Leather Products not including clothing Cuir et imitations du cuir; malles et valises; sacs de voyage, sacs de sport; sacs à main, sacs à dos; sacs de plage, sacs d'écoliers, cartables, sacs à provisions; coffres de voyage; sacs-housses de voyage pour vêtements et souliers; attachés-cases et porte-documents, mallettes pour documents, serviettes (maroquinerie); bourses, portefeuilles, porte-cartes (portefeuilles), porte-monnaie non en métaux précieux, étuis pour clefs (maroquinerie); boîtes en cuir ou en imitation du cuir; trousses de voyage (maroquinerie); coffrets destinés à contenir des articles de toilette dits "vanity cases"; pochettes en cuir, pochettes (sacs à main de soirée); sacs pour transporter les animaux. | |
| YQ YOPLAIT MARQUES 1897137 3 May 2018 | on 5 Jul 2019 | Yogurt Class 029 Class 029 Meats and Processed Food Products Yogurt | |
| AYLYQ GLAXO GROUP LIMITED 1826909 13 Mar 2017 | on 12 Feb 2020 | Pharmaceutical preparations for use as anti-infectives; Pharmaceutical... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use as anti-infectives; Pharmaceutical preparations for the treatment of viral conditions, namely human immunodeficiency virus (HIV), human papilloma virus (HPV), respiratory syncytial virus (RSV), hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders and their symptoms; Pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; Pharmaceutical preparations for the treatment of immunologic diseases and disorders namely, autoimmune diseases and disorders; Pharmaceutical preparations for the treatment of atherosclerosis; Pharmaceutical preparations for the treatment and prevention of metabolic related diseases and disorders namely disorders of the endocrine system, namely growth and thyroid disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management; Pharmaceutical preparations for the treatment and prevention of cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders; Pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of inflammation and inflammatory related diseases and disorders namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis; Pharmaceutical preparations for the prevention and treatment of sequelae of oncologic diseases and their treatment namely nausea and vomiting, hematologic depression, mucositis, cachexia, pain, bone pain and fatigue; Pharmaceutical preparations for the treatment of blood-related diseases and disorders namely thrombocytopenia, coagulation disorders, bleeding disorders, platelet disorders, blood vessel disorders, sickle-cell disease and its related disorders, anemias, sepsis and infections in and of the blood; Pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, cartilage injuries, joint replacement and osteoarthritis; Pharmaceutical preparations for use in ophthalmology; Pharmaceutical preparations for the treatment of dermatological diseases and disorders namely dermatitis, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; Pharmaceutical preparations for the treatment of hormonal related diseases and disorders namely hypogonadism, testosterone/androgen disorders and estrogen disorders; Pharmaceutical preparations for the treatment of gastrointestinal related diseases and disorders namely irritable bowel disorders and symptoms, digestive disorders and acid-related disorders; Pharmaceutical preparations for the treatment of sexual dysfunction namely erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder; Pharmaceutical preparations for the treatment of genitourinary diseases namely urological diseases and disorders; Pharmaceutical preparations for the treatment of gynaecological diseases and disorders namely amenorrhoea, dysmenorrheal and infertility; Pharmaceutical hormonal preparations namely corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; Pharmaceutical preparations for the treatment of incontinence, prostate diseases and disorders, bladder diseases and disorders; Pharmaceutical preparations for the treatment of sexually transmitted diseases, inflammatory pelvic diseases, vasomotor/menopausal symptoms, endometriosis/uterine fibroids, Leiomyoma, endourology/stone, pre-eclampsia and pre-term labour; Pharmaceutical preparations for the treatment of prostatitis, nephritis, cystitis, vaginitis, renal disease; Pharmaceutical preparations for the treatment of premenstrual dysphoric disorder, premenstrual syndrome, male hypogonadism and hormonal disorders namely polycystic ovary syndrome; Pharmaceutical preparations for the treatment of hepatological related diseases namely hepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibroids, and cirrhosis; Pharmaceutical preparations for the treatment of alopecia and androgenic alopecia (male pattern baldness); Pharmaceutical preparations for the treatment of psychiatric diseases and disorders namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; Pharmaceutical preparations for the treatment of damaged skin and tissue namely bee stings, sunburn, rashes, sores, corns, calluses and acne; Pharmaceutical preparations for the treatment of inflammatory connective tissue diseases and injuries; Pharmaceutical preparations for the treatment of malaria; Pharmaceutical preparations for the treatment of tuberculosis; Allergy medications; Vaccines namely prophylactic and therapeutic vaccines for humans; Pharmaceutical preparations for the treatment of neurological diseases and disorders namely Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, depression and anxiety and their related disorders namely schizophrenia and psychoses; Pharmaceutical preparations for the treatment of muscular dystrophy Class 044 Class 044 Medical, Beauty & Agricultural Services Cell and gene therapy services | |
| YQ Younicos GmbH 1793525 28 Jul 2016 | on 25 Feb 2020 | Utility services transmission of electricity, natural gas, water; prov... Class 039 Class 039 Transportation & Storage Services Utility services transmission of electricity, natural gas, water; providing electric power and electric power distribution grid services to electric power distribution grid operators, electric power producers and large energy consumers, namely, industrial and commercial businesses; providing the service of electric power distribution grids, namely, grids containing electric power generator, high voltage electric power transmission grid, and electric power distribution system. | |
| PARTYQ Collins Research, Inc., DBA Flame Foss 1713058 29 Jan 2015 | on 19 May 2016 | Temperature controllers for use in barbecue grills, smokers, barbecue ... Class 009 Class 009 Computer & Software Products & Electrical & Scientific Products Temperature controllers for use in barbecue grills, smokers, barbecue pits, and outdoor ovens. | |